X
Enobia Homepage
Home
|
Search
|
Contact
|
Français
Hypophosphatasia
Key Discoveries in the History of HPP
Clinical Presentation
Diagnosis
Pathophysiology
Epidemiology
Managing HPP
Science
ENB-0040
Pipeline
Glossary
Patients
About Hypophosphatasia
Diagnosing Hypophosphatasia
Treating Hypophosphatasia
How Can I Get Involved in a Clinical Trial for HPP?
Additional Resources
Company
Management Team
Board of Directors
Investors
News
Press Releases
Publications & Presentations
Enobia in the news
Press Releases
Home
»
News
»
Press Releases
print
News
Press Releases
Publications &
Presentations
Enobia in the news
Help us learn more about what it’s like to live with HPP.
> Click here to participate in a survey
Stay Informed
Receive the latest news and updates on hypophosphatasia.
I am a:
select
Doctor
Other
Partner
Patient
Privacy & Confidentiality Policy
Enobia initiates infantile enzyme replacement trial for rare bone disease
December 01, 2008
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
September 22, 2008
Enobia Pharma receives FDA orphan drug designation for Hypophosphatasia product candidate ENB-0040
September 19, 2008
Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
September 15, 2008
Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
August 20, 2008
Press Release Archive:
2010
|
2009
| 2008 |
2007
|
2005
|
View All